Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Olufunmi Ogun"'
Autor:
Ayodeji Salami, Mustapha Ajani, Augustine Adeolu, Olufunmi Ogun, Amos Adeleye, Olabiyi Ogun, Clement Okolo, Adefolarin Malomo, Effiong Akang
Publikováno v:
Alexandria Journal of Medicine, Vol 53, Iss 3, Pp 281-284 (2017)
Background: The WHO has recognized a variant of pituitary adenomas with potential aggressive behaviour which have been termed atypical pituitary adenomas. This group of tumours are recognized by their mitotic rate of more than >3%, p53 expression and
Externí odkaz:
https://doaj.org/article/d1429306e258406abf2c9b2645a147d7
Autor:
Adefolarin O. Malomo, Amos Olufemi Adeleye, Mustapha Akanji Ajani, Effiong E. Akang, Olabiyi G Ogun, Ayodeji Salami, Clement A. Okolo, Olufunmi Ogun, A A Adeolu
Publikováno v:
Alexandria Journal of Medicine, Vol 53, Iss 3, Pp 281-284 (2017)
Alexandria Journal of Medicine; Vol 53, No 3 (2017); 281-284
Alexandria Journal of Medicine; Vol 53, No 3 (2017); 281-284
Background: The WHO has recognized a variant of pituitary adenomas with potential aggressive behaviour which have been termed atypical pituitary adenomas. This group of tumours are recognized by their mitotic rate of more than >3%, p53 expression and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1de84589dfa2b021dcd6c0bd0b4d8d91
https://doi.org/10.1016/j.ajme.2016.11.003
https://doi.org/10.1016/j.ajme.2016.11.003
Autor:
Olufunmi Ogun, E E Akang, Gabriel O. Ogun, Michael Chukwugoziem Nweke, A Lawan, S Abubakar-Akanbi, Ayodeji Salami, T Babatunde
Publikováno v:
Annals of Tropical Pathology. 8:47
Pituitary macroadenomas are rare tumors constituting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5568db37915a543febc7baad91481258
https://doi.org/10.4103/atp.atp_15_17
https://doi.org/10.4103/atp.atp_15_17
Autor:
Adeyinka O. Ashaye, Charles O. Bekibele, AM Baiyeroju, Adekunmi O. Ibrahim, Olufunmi Ogun, Oluyemi Fasina, Bolutife A Olusanya
Publikováno v:
International ophthalmology. 32(1)
To compare the efficacy of 5-fluorouracil (5-FU) with mitomycin C (MMC) in preventing pterygium recurrence when used as an adjuvant following pterygium excision with conjunctival autograft. Low-dose MMC combined with conjunctival autograft is an effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c7f1e7df1dda44235719672df924b78
https://pubmed.ncbi.nlm.nih.gov/22246200
https://pubmed.ncbi.nlm.nih.gov/22246200